Ixtlan BioScience

Psilocybin-based Treatments for Brain Pathologies

Health Tech & Life Sciences

Non Active, Aug 2024 ceased to operate

Pre-Funding Caesarea Founded 2020

Total raised

—

Stage

Pre-Funding

Founded

2020

Headcount

Caesarea

Sector

Health Tech & Life Sciences

About

Ixtlan Bioscience is focused on developing a psilocybin-based treatment for Alzheimer's disease and other brain pathologies. The company is devoted to defining and utilizing psilocybin micro-dosing in order to find a new and better class of safe and accessible mental health therapies to slow down the progression of Alzheimer's and dementia diseases.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue Engineering

Technologies

BiologicalsHerbals

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticals

Business model

B2B

Highlights

Verified

Name	Ixtlan BioScience
Slug	ixtlan-bioscience
Type	Israeli Startup
Founded	2020
HQ city	Caesarea
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Pre-Funding
Public stage	Pre-Funding
Total raised (USD)	0
Israeli Companies Registrar	516460052

Name	Role	LinkedIn
Yehonatan Cavens
Itamar Bar-Av Borochov
Shlomo Pekar
Ana Parabucki

Ixtlan BioScience

About

Sectors & technology

Highlights

Tags